Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
TABLE OF CONTENTS | ||||||||||||||||||||||||||||||||||||||||||||||
September 2015 Volume 15 Number 9 | ||||||||||||||||||||||||||||||||||||||||||||||
In this issue Research Highlights Reviews Perspectives
| ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
REVIEWS | Top | |||||||||||||||||||||||||||||||||||||||||||||
The dynamic control of signal transduction networks in cancer cells Walter Kolch, Melinda Halasz, Marina Granovskaya & Boris N. Kholodenko p515 | doi:10.1038/nrc3983 Cancer cells exhibit huge phenotypic plasticity, which can lead to adaptations to the tumour microenvironment and therapy. Much of this plasticity seems to be encoded in signal transduction networks, such that alterations in signalling dynamics can affect many cancer-associated phenotypes and therapeutic response. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||||||||||
Deoxyribonucleotide metabolism, mutagenesis and cancer Christopher K. Mathews p528 | doi:10.1038/nrc3981 This Review discusses nucleotide metabolism and how fluctuations in deoxyribonucleoside triphosphate (dNTP) pools affect genomic instability. Drugs that target this system have been in use for many years and some of these are discussed, as well as newer approaches to manipulating deoxyribonucleotide metabolism for cancer treatment. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||||||||||
Glycosylation in cancer: mechanisms and clinical implications Salome S. Pinho & Celso A. Reis p540 | doi:10.1038/nrc3982 This Review discusses the importance of glycobiology in cancer research, given its role in cancer development and progression, and provides an overview of possible targets for diagnostic application and therapeutic strategies. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||||||||||
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
PERSPECTIVES | Top | |||||||||||||||||||||||||||||||||||||||||||||
OPINION Article series: Cancer origins Imaging innate immune responses at tumour initiation: new insights from fish and flies Yi Feng & Paul Martin p556 | doi:10.1038/nrc3979 This Opinion describes the early interactions between immune cells and pre-neoplastic cells observed in translucent zebrafish and Drosophila melanogaster models, and speculates on their potential implications in human cancer. Abstract | Full Text | PDF | Supplementary information | ||||||||||||||||||||||||||||||||||||||||||||||
OPINION Sympathetic nervous system regulation of the tumour microenvironment Steven W. Cole et al. p563 | doi:10.1038/nrc3978 Activation of the peripheral nervous system can promote metastasis of primary tumours. This Opinion article discusses the molecular mechanisms through which physiological stress can have an effect on cancer, and how pharmacological antagonism of β-adrenergic signalling might represent a therapeutic opportunity to target cancer progression. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||||||||||
|
*2013 Journal Citation Report (Thomson Reuters, 2014) |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
No comments:
Post a Comment